Article Text
Statistics from Altmetric.com
The said truth is that it is the greatest happiness of the greatest number that is the measure of right and wrong.
Jeremy Bentham (1748–1832)
The “greatest happiness principle” propounded by 19th century Utilitarian philosophers such as Jeremy Bentham and John Stuart-Mill directs that “right” actions are those which do the greatest good for the greatest number. Even if this philosophical principle has fallen into disrepute, having found its purest expression in the totalitarian excesses of fascism and communism, utilitarianism seems like a promising moral foundation, at least for public health medicine. However, medical research tends to be driven by the intellectual interests of individual researchers and rare diseases appear more often on grant applications than can be justified simply by the number of people affected. A commonly stated defence is that by understanding the pathophysiology of rare diseases we will learn something of importance about more common conditions. Are there good examples from neurology to support this approach?
Most genetic diseases are rare whereas most common diseases are considered to be “complex”, by …
Read the full text or download the PDF:
Other content recommended for you
- Alzheimer’s disease, amyotrophic lateral sclerosis, and transgenic mice
- Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy
- Science, medicine, and the future: Alzheimer's disease
- Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
- Neuronal network disintegration: common pathways linking neurodegenerative diseases
- The −48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain
- Protein aggregates and dementia: is there a common toxicity?
- Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained
- Regulation of Cerebral Cholesterol Metabolism in Alzheimer Disease
- Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update